🇿🇦 Bioavailability & Bioequivalence (BA/BE) Studies Services for Africa

BioEquiGlobal – Africa

BA/BE Studies & Comparative Dissolution Services for African Regulatory Markets

Fast. Reliable. Regulatory-Ready Bioequivalence Studies.

BioEquiGlobal, a scientific service platform of Zoesoe Exports Pvt Ltd, provides end-to-end Bioavailability (BA) and Bioequivalence (BE) study services along with comparative dissolution profiling for pharmaceutical products targeting African regulatory markets.

We support pharmaceutical manufacturers exporting medicines to African Ministries of Health (MOH) with GCP-compliant clinical studies, validated bioanalytical methods, and regulatory-ready documentation aligned with African regulatory requirements.

Our integrated approach combines clinical research, pharmacokinetics, bioanalysis, and regulatory expertise to help companies achieve faster medicine approvals across African markets.

Our Core Services

✅ Clinical BA/BE Studies (Human)

• Single-dose and multiple-dose studies
• Crossover and parallel study designs
• Studies conducted in healthy volunteers or patient populations where required
• Clinical conduct aligned with Good Clinical Practice

These studies support generic drug approvals across African regulatory authorities.

✅ Comparative Dissolution Profiling

• Routine dissolution testing
• Biorelevant dissolution media
• Sink and non-sink dissolution conditions

Data analysis includes:

• Similarity factor (f2) comparison
• Model-independent dissolution analysis
• Model-dependent dissolution modeling

Comparative dissolution studies are frequently required for biowaiver justification and formulation equivalence evaluation.

✅ In Vitro – In Vivo Correlation (IVIVC)

• Level A, Level B, and Level C IVIVC models
• Predictive pharmacokinetic modeling
• Support for regulatory biowaiver strategies

IVIVC helps reduce regulatory risk and supports efficient pharmaceutical product development.

✅ Bioanalytical Method Development & Validation

Validated analytical methods using:

• LC-MS/MS platforms
• HPLC-UV analytical methods
• Stability-indicating methods

All methods are validated in accordance with **International Council for Harmonisation guidelines including ICH M9.

✅ Pharmacokinetic (PK) Analysis & Statistical Evaluation

• Non-compartmental pharmacokinetic analysis
• Bioequivalence statistical evaluation
• Sample size and power calculations
• Regulatory statistical reports

✅ Regulatory Dossier Preparation

BioEquiGlobal prepares complete regulatory documentation for African pharmaceutical submissions, including:

• Clinical Study Protocols
• Clinical Study Reports (CSR)
• Bioanalytical validation reports
• Comparative dissolution reports
• CTD-ready dossier modules

These documents support submissions to African Ministries of Health and regional regulatory authorities.

GCP / GLP Compliance & Quality Assurance

All studies are conducted under internationally recognized quality systems:

• Good Clinical Practice
• Good Laboratory Practice

Quality systems include:

• Internal QA audits
• SOP-driven study operations
• Data integrity and audit trails
• Regulatory inspection readiness

Why Choose BioEquiGlobal?

✔ Regulatory-focused study design aligned with African authorities
✔ Experienced multidisciplinary scientific team
✔ Accredited clinical units and validated analytical laboratories
✔ Dedicated project management and milestone tracking
✔ Cost-effective study execution
✔ High standards of data integrity and regulatory compliance

Our Study Workflow

BioEquiGlobal follows a structured study lifecycle ensuring regulatory-ready results.

1️⃣ Project Feasibility & Regulatory Gap Analysis

• Product profile assessment
• Reference product selection
• Biowaiver feasibility evaluation

2️⃣ Protocol Development & Regulatory Strategy

• Clinical study protocol
• Statistical analysis plan
• Ethics committee approvals

3️⃣ Bioanalytical Method Development & Validation

• Analytical method development
• Validation according to regulatory guidance

4️⃣ Clinical Study Conduct

• Volunteer recruitment
• Clinical dosing and monitoring
• Sample collection and handling under GCP

5️⃣ Bioanalysis & PK Analysis

• Sample quantification using validated analytical platforms
• Pharmacokinetic evaluation
• Bioequivalence statistical analysis

6️⃣ Study Reports & Regulatory Submission

• Clinical Study Report (CSR)
• Comparative dissolution reports
• CTD-ready regulatory documentation

Comparative Dissolution: Our Scientific Approach

BioEquiGlobal ensures robust dissolution comparison through:

• Biorelevant dissolution testing
• Physiologically relevant dissolution media
• Similarity factor (f2) analysis
• Model-based dissolution comparison
• Integration of dissolution and pharmacokinetic data

These approaches help support biowaiver claims and regulatory acceptance.

Regulatory & Quality Compliance

BioEquiGlobal operates in alignment with international and African regulatory expectations including:

• World Health Organization pharmaceutical guidelines
• ICH M9
• African Medicines Agency regulatory harmonization initiatives
• National MOH regulatory frameworks across Africa

Who We Work With

BioEquiGlobal supports:

• Generic pharmaceutical manufacturers
• Pharmaceutical exporters targeting African markets
• Contract research organizations (CROs)
• Formulation development companies
• Regulatory consulting organizations

Africa Market Coverage

BioEquiGlobal supports BA/BE studies and regulatory submissions for pharmaceutical products across African regulatory markets, including:

🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇹🇿 Tanzania
🇺🇬 Uganda
🇪🇹 Ethiopia
🇿🇲 Zambia
🇧🇼 Botswana
🇿🇦 South Africa
🌍 Other African MOH jurisdictions

Fast Facts

Clinical Units

• Phlebotomy and clinical monitoring facilities
• Emergency medical response capability
• Comfortable volunteer accommodation

Analytical Platforms

• LC-MS/MS systems
• HPLC analytical systems
• Validated bioanalytical workflows

Deliverables

• Clinical study protocol
• Clinical Study Report (CSR)
• Bioanalytical method validation report
• Pharmacokinetic statistical report
• Comparative dissolution profiles
• CTD-ready regulatory documentation

Partner with BioEquiGlobal

Accelerate generic drug approvals across African pharmaceutical markets with scientifically robust and regulatory-ready BA/BE studies.

From clinical studies to regulatory submissions, BioEquiGlobal is your trusted partner for Africa-focused pharmaceutical development and regulatory approvals.